- Home
- / Oyster Point Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Oyster Point Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$11.2
2023-01-11
Market Capitalization
$292.3 M
2023-01-11
Revenue
$24.5 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|
| Revenue | 24.5M | ||||
| Cost of goods sold | 1.5M | ||||
| General and administrative expense | 2.1M | 3.0M | 13.7M | 31.2M | 40.8M |
| Operating expense total | 5.7M | 16.7M | 47.3M | 71.0M | 119.7M |
| EBIT | (5.7M) | (16.7M) | (47.3M) | (71.0M) | (96.7M) |
| Interest income | 44.0K | 233.0K | 1.6M | 469.0K | |
| Pre tax profit | (45.7M) | ||||
| Net Income | (19.1M) | (16.5M) | (45.7M) | (70.5M) |